IPO
Anebulo Pharmaceuticals, Inc
Biotechnology
We are a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Our lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration.
Symbol
ANEB
Price Range
$6.00 - $8.00
Anticipated Date
May 7, 2021
Underwriters
THE BENCHMARK COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Anebulo Pharmaceuticals, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277